I see them as competing with PGL in this space of primary liver cancer, so if they can't make it to the next level I guess it is good news for PGL.
bioalliance pharma suspends phase ii iii trial, page-3
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.42M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 44.0¢ | $247.5K | 562.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56438 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 263294 | 5 |
View Market Depth
| Last trade - 14.03pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
44.5¢ |
Change
0.000 ( 1.14 %) |
||||
| Open | High | Low | Volume | ||
| 44.5¢ | 44.5¢ | 44.5¢ | 1150 | ||
| Last updated 10.51am 18/06/2024 ? | |||||
| PGL (ASX) Chart |